Everest Medicines Limited
Industry
- Biotechnology
- Large Molecule
- Antibodies
- Large Molecule
- Pharmaceuticals
- Specialty Pharmaceuticals
Other Names/Subsidiaries
- EverNov
Latest on Everest Medicines Limited
Asahi Kasei Corporation aims to build on the US presence it established and the health care business growth it jumpstarted when it bought Veloxis Pharmaceuticals A/S by paying approximately $1.1bn
Calliditas Therapeutics AB 's bid to get a second asset across the regulatory finishing line – following its immunoglobulin A nephropathy (IgAN) treatment Tarpeyo – seems to have been boosted despite
The month of March will bring eight more chances for the US FDA to approve novel drugs and biologics, potentially providing a corrective to 2024’s slow start for innovative approvals. The number of us
Amid an ongoing capital crunch, Chinese drug makers pursuing in-licensing models have arrived at a commercialization crossroads. Jump-started by frontrunner Zai Lab Ltd. ’s successful introduction of